22/05/2026
🎉CELEBRATING A MAJOR MILESTONE IN BRAIN HEALTH🎉|
✨ 🧠AUSTRALIAN EPILEPSY PROJECT (AEP) AWARDED $30M TO TRANSFORM BRAIN HEALTH IN AUSTRALIA 🧠✨
The Australian Epilepsy Project (AEP) are thrilled to announce we have received an additional $30 million through the MRFF to expand its groundbreaking brain health platform across the Australian health system. Using AI-powered technology that combines advanced MRI, genetics and cognitive testing, the AEP is establishing a national standard of care for epilepsy, helping Australians access faster diagnosis, more personalised treatment, and better long-term outcomes.
Most importantly, we are already seeing real impact for people living with epilepsy, and our team is incredibly proud of what has been achieved so far. This funding is a real step forward for people living with epilepsy and will allow us to help many more individuals and families across Australia in the years ahead.
This funding will enable the AEP to:
• Expand access to advanced diagnostics and specialist expertise across more hospitals and clinics nationally
• Scale precision epilepsy care across Australia
• Develop future solutions for neurological and mental health conditions beyond epilepsy
• Accelerate commercialisation and international expansion of Australian-developed health technology
Chief Investigator, Prof. Graeme Jackson said:
“Digital technologies and AI can translate research into new optimised models of health care at population scale. This brings the highest standard of care to the whole population regardless of where you live, with particular impact for rural and regional Australia. This is the future.”
He added:
“The Australian Epilepsy Project has successfully established a high standard of care for epilepsy, bringing advanced research to clinical impact in a platform model that connects patients with their doctors and ongoing research.”
Executive Lead, Anton de Weger said:
“Securing this four-year federal investment allows us to move from a frontier clinical project to an established translation platform.”
“Scaling AI-enabled digital care pathways requires a multidisciplinary team spanning deep neurological science, startup and commercial acumen, clinical expertise, lived experience, data science and engineering.”
“This grant provides the precise runway needed to build innovative, regulated, automated tools that scale impact and change the standard of care for brain health, proving Australia can lead the world in health-tech commercialisation.”
Read more: https://www.health.gov.au/ministers/the-hon-mark-butler-mp/media/delivering-world-class-health-and-medical-research-for-australia?language=en
The Florey Institute of Neuroscience and Mental Health
Mark Butler MP